TY - T1的原发性胆汁胆管炎和特别行政区S-CoV-2 infection: incidence, susceptibility and outcomes JF - Gut JO - Gut SP - 2138 LP - 2140 DO - 10.1136/gutjnl-2021-325700 VL - 71 IS - 10 AU - Javier Ampuero AU - Ana Lucena AU - Manuel Hernández-Guerra AU - Isabel Moreno-Moraleda AU - Juan Arenas AU - Isabel Conde AU - Laura Muñoz AU - Lidia Canillas AU - Edgar Fernandez AU - Raisa Quiñones AU - Miguel Angel Simon AU - Elena Gómez-Dominguez AU - Maria Luisa Gutierrez AU - Conrado Fernandez-Rodriguez AU - Maria Jose Domper-Arnal AU - Francisco Jorquera AU - Maria Luisa Garcia-Buey AU - Montserrat Garcia-Retortillo AU - Rosa Morillas AU - Marina Berenguer AU - Marta Casado AU - Dalia Morales-Arraez AU - José Manuel Sousa AU - Esther Molina Y1 - 2022/10/01 UR - //www.marcconsult.com/content/71/10/2138.abstract N2 - We read with interest the work by Mansoor et al 1 regarding the outcomes of COVID-19 in coeliac disease. The impact of pre-existing chronic liver diseases on COVID-19 outcomes has been largely evaluated,2–4 and consequently specific recommendations have been made in these patients.5 However, the relationship between primary biliary cholangitis (PBC) and SARS-CoV-2 remains unknown.6 We aimed to determine (1) the cumulative incidence of SARS-CoV-2 infection in a population of patients with PBC, comparing with the general Spanish cumulative incidence by the end of April 2021; (2) the baseline factors associated with a higher susceptibility to SARS-CoV-2 infection; and (3) the baseline factors associated with COVID-19-related hospitalisation.We performed a multicentre retrospective study enrolling 1151 patients from 13 Spanish referral hospitals. We collected information about SARS-CoV-2 infection from medical records of all patients with PBC from January 2020 to April 2021 (online supplemental material 1). Exclusion criteria were patients who died before January 2020, liver transplant before or after the enrolment and patients having received some dose of a vaccine against SARS-CoV-2.Supplementary data [gutjnl-2021-325700supp001.pdf] The Spanish government officially publishes the prevalence, incidence and outcomes of SARS-CoV-2 (https://www.mscbs.gob.es/). For this study, data were accessed on 30 April 2021. The … ER -